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Summary
 
Herpes simplex virus type 1 (HSV1), a large DNA-containing virus, is endemic in all human
populations investigated. After infection of mucocutaneous surfaces, HSV1 establishes a latent
infection in nerve cells. Recently, it was demonstrated that HSV1 can also infect activated T
lymphocytes. However, the consequences of T cell infection for viral pathogenesis and immu-
nity are unknown. We have observed that in contrast to the situation in human fibroblasts, in
human T cell lines antigen presentation by major histocompatibility complex class I molecules
is not blocked after HSV1 infection. Moreover, HSV1 infection of T cells results in rapid elim-
ination of antiviral T cells by fratricide. To dissect the underlying molecular events, we used a
transgenic mouse model of HSV1 infection to demonstrate that CD95 (Apo-1, Fas)-triggered
apoptosis is essential for HSV1-induced fratricide, whereas tumor necrosis factor (TNF) also
contributes to this phenomenon but to a lesser extent. By contrast, neither TRAIL (TNF-related
apoptosis-inducing ligand) nor perforin were involved. Finally, we defined two mechanisms
associated with HSV1-associated fratricide of antiviral T cells: (a) T cell receptor–mediated up-
regulation of CD95 ligand and (b) a viral “competence-to-die” signal that renders activated T
lymphocytes susceptible to CD95 signaling. We propose that induction of fratricide is an im-
portant immune evasion mechanism of HSV1, helping the virus to persist in the host organism
throughout its lifetime.
Key words: viral immune evasion • apoptosis • activation-induced cell death • herpes simplex 
virus • antigen presentation
 
H
 
erpes simplex virus type 1 (HSV1), a member of the
subfamily 
 
alphaherpesviridae
 
, is an important neuro-
tropic virus with a worldwide distribution. After primary
infection, HSV1 becomes latent in neurons. From there it
can periodically emerge to reinfect skin or other tissues,
causing recurrent mucocutaneous lesions in about one third
of the human population (1, 2). In rare cases, the virus spreads
within the central nervous system to cause life-threatening
encephalitis. Numerous reports have demonstrated that T
cells are necessary for clearing HSV1 infections and that
CD8
 
1
 
 antiviral CTLs play a pivotal role in the elimination
of most viruses. However, herpesviruses have evolved deli-
cate strategies to evade the attack of T cells, enabling them
to persist and reactivate in the host, usually without causing
significant tissue damage (3, 4).
In the course of viral infection, a population of CTL
precursor cells with a TCR repertoire strongly skewed to-
ward viral antigens is activated in the draining lymph nodes
and, in the case of HSV1 infections, subsequently migrates
to the site of viral replication in the epithelium (5). There,
HSV virions can productively infect the antiviral CTL be-
cause HSV1 has been shown to enter activated T lympho-
cytes (6, 7) after binding of the viral glycoprotein D (gD)
 
1
 
to the herpesvirus entry mediator molecule (HVEM), a novel
member of the TNF/nerve growth factor receptor family
expressed by activated T cells (8, 9).
HSV1, like other large DNA-containing viruses, employs
multiple viral defense mechanisms that cooperate to pre-
vent premature death of the host cell induced by a variety
of intracellular and extracellular signals. The virus thereby
increases the yield of viral progeny after lytic infection of its
main target cells. Whether a particular viral defense mecha-
nism is operative depends on the HSV1-infected cell type
 
1
 
Abbreviations used in this paper:
 
 AICD, activation-induced cell death; gD,
glycoprotein D; L, ligand; MOI, multiplicity of infection; SEB, staphylo-
coccal enterotoxin B; TRAIL, TNF-related apoptosis-inducing ligand;
TUNEL, TdT-mediated dUTP-biotin nick-end labeling. 
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(10). It has been reported for various cell types other than
CTLs that HSV proteins can block apoptosis that has been
triggered as a direct response of the host cell to virus infec-
tion (cell-autonomous apoptosis) (10–12). In infected human
fibroblast cell lines, HSV1 has also been shown to evade
attacking antiviral CTLs by preventing the transport of
MHC class I molecules to the cell surface (13, 14) and by
conferring resistance to CTL-induced antigen-dependent
apoptosis (15). As viral replication in CTLs is limited, the
contribution of T cell infection to the overall production of
infectious HSV1 particles is marginal. This raises two im-
portant questions: Are viral defense mechanisms operative
in infected T lymphocytes and, more importantly, Why are
activated T cells the target of HSV1?
In this paper, we analyze the functional consequences of
HSV1 infection for activated antiviral T lymphocytes and
show that HSV1 removes the block by which activated CTLs
protect themselves from inflicting “self injury” (16–20). On
the basis of these data, we propose a scenario of viral im-
mune evasion in which infected antiviral T lymphocytes
serve as decoy targets and kill each other (fratricide) instead
of infected epithelium, the main cell type producing HSV1
virions.
 
Materials and Methods
 
Cells and Media.
 
CV1 African green monkey kidney cells were
used for propagation and titration of the virus. For studies of K
 
b
 
expression and T cell activation, NIH 3T3 murine fibroblast cells
or the murine mastocytoma cell line P815 and derived transfec-
tants were employed, namely: P815-K
 
b
 
 expressing the gene for
the heavy chain of the murine MHC class I molecule K
 
b
 
 (21),
P815-B7 expressing the human B7.1 (22), and P815-K
 
b
 
-B7, which
express both molecules on the cell surface (21). Human embry-
onic lung fibroblasts (HELs), the human lymphoblastoma cell line
Jurkat, and human PBMCs isolated from units of buffy coat sup-
plied from the University of Heidelberg blood bank were used for
investigation of HSV1 infection of human cells. CV1, NIH 3T3,
P815, and HEL cells were maintained in DMEM supplemented
with 10% FCS, 100 IU penicillin, 100 
 
m
 
g/ml streptomycin, and
4 mM 
 
l
 
-glutamine (DM medium). Transfectants of P815 cells
were maintained in the same medium with a supplement of
0.4 mg/ml G418 (GIBCO BRL). Murine splenocytes and Jurkat
cells were grown in RPMI 1640 supplemented with 10% heat-
inactivated FCS, 100 IU penicillin, 100 
 
m
 
g/ml streptomycin, 4 mM
glutamine, 10 mM Hepes, and 50 
 
m
 
M 2-ME (RP medium). Hu-
man PBMCs were propagated in the same medium, except that
FCS was replaced with 10% heat-inactivated pooled human AB
serum (RP-h medium).
 
Viruses and Infection.
 
F-US5MHC (recombinant HSV1 express-
ing murine 
 
b
 
2-microglobulin and H-2K
 
b
 
) and F-US5
 
b
 
 (express-
ing 
 
b
 
-galactosidase), which are identical with respect to HSV1
genes other than the transgenes, were gifts of D.C. Johnson (Mc-
Master University, Hamilton, Ontario, Canada; 13). HSV1 strain
F, from which both recombinant viruses were derived, was ob-
tained from American Type Culture Collection (ATCC). A mu-
tant HSV1 strain F that lacks the transporter associated with anti-
gen processing blocking protein ICP47 (F-ICP47
 
D
 
) was a gift of
R.L. Hendricks (University of Illinois, Chicago, IL; 23). For pro-
duction of virus stock supernatant, HSV1-infected CV1 cell cul-
 
tures were centrifuged at 10,000 
 
g
 
 and then filtered with a 0.45-mm
mesh filter to remove cellular debris before being pelleted for
1.5 h at 43,000 
 
g
 
. The viral pellet was resuspended in RPMI with
10% heat-inactivated FCS and then frozen at 
 
2
 
80
 
8
 
C to give a
concentrated viral stock. Frozen viral stocks were titrated using
the endpoint dilution method, tested for the presence of myco-
plasma using the mycoplasma detection kit (Boehringer Mann-
heim), and used within 4 mo of manufacture. To infect cells, virus
was added to a minimal quantity of the medium appropriate for
various cell types and then cultured for 1 h at 37
 
8
 
C. Subse-
quently, cells were washed three times with PBS to remove un-
adsorbed virus before adding fresh medium.
 
Animals.
 
K
 
b
 
-specific TCR (Des.TCR)-transgenic mice have
been previously described (24). These transgenic animals express
the rearranged TCR-
 
a
 
 and -
 
b
 
 genes derived from CTL clone
KB5.C20, which is allospecific for the K
 
b
 
 antigen (25). Perforin-
deficient mice (26) were provided by Dr. H. Hengartner (Uni-
versity of Zürich, Zürich, Switzerland). Des.TCR and perforin-defi-
cient mice were crossed and kept under pathogen-free conditions
in the animal facility of the German Cancer Research Center
(Heidelberg, Germany). Female DBA/2 and C57Bl/6 mice, 4–6 wk
old, were purchased from Charles River Labs. and maintained in
the animal facility of the University of Heidelberg.
 
Irradiation.
 
Gamma irradiation of 8,000 rads was found to be
equally effective in preventing either cellular (P815 cells and T
cell blasts) proliferation or HSV1 replication.
 
Preparation and Stimulation of CTLs.
 
Mononuclear cells were
isolated from murine splenocytes or human peripheral blood by
separation over Ficoll-Paque™ columns (Amersham Pharmacia
Biotech). To generate murine T cell blasts by polyclonal stimula-
tion, cells were incubated at a density of 2.5 
 
3
 
 10
 
6
 
 cells/ml in RP
medium with 2.5 
 
m
 
g/ml Con A for 2 d. As CD8
 
1
 
 T cells derived
from Des.TCR splenocytes are 
 
.
 
90% positive for the transgenic
K
 
b
 
-reactive TCR, and because Des.TCR CD4
 
1
 
 T cells are func-
tionally inert, polyclonal stimulation of Des.TCR splenocytes
yields K
 
b
 
-reactive CD8
 
1
 
 T cells without further purification. For
generation of CTLs specifically activated against K
 
b
 
, mononuclear
cells from Des.TCR-transgenic mice were incubated with irradi-
ated P815-K
 
b
 
-B7 cells at a ratio of 5:1 for 3 d in RP medium.
 
Purification of Murine CD8
 
1
 
 Lymphocytes.
 
To generate pure ac-
tivated murine CD8
 
1
 
 cells, Con A–stimulated mononuclear cells
were initially depleted of professional APCs by incubation for 1 h
on a Sephadex G-10 column (Amersham Pharmacia Biotech).
For removal of B cells, the remaining nonadherent cells were in-
cubated with anti–mouse IgG magnetic beads (Paesel & Lorei).
Murine CD8
 
1
 
 cells were then isolated by depletion of other cell
populations by passing over a CD8 negative selection column (R
& D Systems, Inc.). The remaining cells were 
 
.
 
95% CD8
 
1
 
 cells.
 
Preparation and Stimulation of HSV1-reactive Lymphocytes.
 
Mu-
rine mononuclear cells were prepared from the spleens of DBA/2
mice infected 6 wk before with 2.5 
 
3
 
 10
 
6
 
 PFU of HSV1 strain F
injected intraperitoneally in 100 
 
m
 
l PBS. Human mononuclear
cells were prepared from the peripheral blood of HSV1-positive
donors, and aliquots were frozen at 
 
2
 
80
 
8
 
C, one aliquot being re-
tained and cultured in RP-h medium with 4 
 
m
 
g/ml PHA for 24 h
to generate activated T cells. Murine splenocytes from DBA/2
mice were activated with 2.5 
 
m
 
g/ml Con A. Stimulator cells
were then prepared by infecting murine DBA/2 or human T cell
blasts with HSV-1 F-ICP47
 
D
 
 mutant at a multiplicity of infec-
tion (MOI) of 2 and incubating for 24 h before irradiation. Stim-
ulator cells were then incubated with responder cells at a ratio of
1:5 in RP or RP-h medium for 72 h before half of the medium
was changed and recombinant IL-2 (human or murine) added at 
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a concentration of 40 (human) or 90 (murine) U/ml. Medium re-
plenishment was repeated every 3 d. On day 9, cells were removed
by Ficoll-Paque™ purification and, when required, CD4
 
1
 
 or CD8
 
1
 
cells positively selected by biotinylated anti-CD4 or anti-CD8 anti-
body and streptavidin-coated magnetic particles using the MACS™
system (Miltenyi Biotec). The purified HSV1-reactive T cells were
incubated with fresh stimulator cells in the relevant medium with
IL-2 for a further 48 h before being used in JAM assays.
Polyclonally stimulated human or mouse T lymphocytes were
generated using PHA (4 
 
m
 
g/ml) or Con A (2.5 
 
m
 
g/ml), respec-
tively, as the initial stimulus. Polyclonally activated T cells were
cultured as described for HSV1-reactive T lymphocytes except
that they were restimulated with PHA and Con A, respectively,
in combination with uninfected irradiated stimulator cells.
 
Preparation and Stimulation of Human CMV-reactive T Cells.
 
For
preparation of HCMV-reactive T cells, PBMCs were isolated from
HCMV-positive donors and frozen. Monocytes were isolated by
adhesion to tissue culture dishes, harvested, and then mixed with
mononuclear cells at a ratio of 3:1 in RP-h medium supple-
mented with 4 
 
m
 
g/ml PHA. After 4 d of cultivation, the stimu-
lated monocytes/macrophages were infected with a clinical strain
of human (H)CMV (HCMV-N) at an MOI of 5, washed, and
recultivated for a further 3 d before irradiation. Thereafter, these
cells were used to stimulate autologous T cells essentially as de-
scribed for HSV1-reactive T lymphocytes.
 
Flow Cytometry.
 
Standard procedures were used for flow cy-
tometric analysis (27). In brief, for surface immunofluorescence,
cells in suspension were washed once with ice-cold wash solution
(PBS with 2% BSA and 0.05% sodium azide) before being resus-
pended with the first antibody in ice-cold blocking solution (PBS
with 10% heat-inactivated FCS and 0.2% sodium azide) for 45
min. The cells were then washed in ice-cold wash solution and
the staining repeated with a secondary antibody (where relevant).
After the final staining step, the cells were washed in ice-cold
PBS and then either resuspended in 200 
 
m
 
l blocking solution for
measurement or fixed in 4% ice-cold paraformaldehyde for 30
min. Fixed cells were washed twice with ice-cold PBS before be-
ing stained by the TUNEL (TdT-mediated dUTP-biotin nick-
end labeling) method. For TUNEL staining, fixed cells were
permeabilized by ice-cold 0.1% Triton X-100 with 0.1% sodium
citrate for 2 min before being washed twice with ice-cold PBS.
Fixed permeabilized cells were then incubated for 1 h at 37
 
8
 
C
with TUNEL solution (TUNEL staining kit; Boehringer Mann-
heim) before being washed twice with room temperature PBS.
Flow cytometry was performed on a FACScan™ (Becton Dickin-
son) linked to an Apple Macintosh Quadra 650 using CELLQuest™
software (Becton Dickinson) for data analysis.
 
Antibodies and Chimeric Proteins.
 
The following reagents were
employed for FACS staining: FITC-coupled Désiré-1 as a clono-
type-specific mAb to monitor the transgenic TCR (24, 28), and
antibodies against murine CD8
 
a
 
 (clone Ly-2), H-2K
 
b
 
 (clone AF6-
88.5), CD95 (clones DX2 and JO2), CD95L (ligand; clone MFL3),
human CD8 (clone RPA-T8), and human CD4 (clone RPA-
T4), purchased from PharMingen. Antibody against viral gD was
obtained from Advanced Biotechnologies, Inc. The hybridoma
producing antibody W6/32, specific for MHC class I, was obtained
from ATCC. Secondary antibodies and streptavidin-linked fluoro-
chromes were obtained from Southern Biotechnology Associates.
Chimeric proteins consisting of the extracellular portion of murine
CD95, human TNF-related apoptosis-inducing ligand (TRAIL)R2,
and human TNFR2 combined with the Fc portion of human
IgG were produced by transient transfection of COS7 cells with
expression plasmids encoding the various proteins in pcDNA3.9
 
(Invitrogen Corp.) and subsequent purification on protein G–Seph-
arose columns (Amersham Pharmacia Biotech).
 
51
 
Cr-Release Assay.
 
P815 cells or CD8
 
1
 
 cells from DBA/2
mice were infected with HSV strain F, F-US5
 
b
 
, or F-US5MHC at
an MOI of 10 and incubated for 4 h. Cells were then used as target
cells in a 
 
51
 
Cr-release assay as described elsewhere (29). 
 
51
 
Cr was
obtained from New England Nuclear. 
 
JAM Test.
 
The JAM assay (30) was performed to measure
the degree of cell death. For this purpose, target cells are labeled
with tritiated thymidine. If apoptosis occurs in the labeled cell
population, DNA fragments will be washed through glass fiber
filters during cell harvesting. In contrast, DNA from surviving
target cells remains intact and will be captured by the filters. The
percent cell death can be calculated by comparing the amount of
[
 
3
 
H]thymidine bound to filters in the presence and absence of the
apoptosis-inducing event. In brief, proliferating lymphocytes were
pulsed overnight with tritiated thymidine at a concentration of
5 
 
m
 
Ci/ml (New England Nuclear). Cellular debris was removed
by Ficoll-Paque™ purification, and the cells were washed twice
with wash medium (RPMI with 5% heat-inactivated FCS) and
counted before being used as target cells. Infected or uninfected
target cells were incubated for 7 h at a density of 100,000 cells in
200 
 
m
 
l proliferation medium in round-bottom 96-well plates be-
fore being harvested and counted. When required, blocking anti-
bodies or chimeric proteins were added 2 h after infection at the
specified concentrations. All measurements given represent the
mean of six or eight wells, and all experiments were replicated at
least once on separate occasions. The highest MOI used was 10 to
avoid inhibition of cytotoxic activity by HSV1 as has been previ-
ously reported (31).
 
Apoptosis Induction in Staphylococcus Enterotoxin B–stimulated
PBMCs.
 
PBMCs were stimulated with staphylococcal entero-
toxin B (SEB) at a concentration of 1 mg/ml for 24 h. Cells were
then either infected with HSV1 strain F at an MOI of 10 or mock
infected and then incubated for a further 18 h with apoptosis-
inducing anti-CD95 mAb. Cells were then stained for CD8 or
CD4 and used in the TUNEL assay.
 
Results
 
HSV1 Does Not Block MHC Class I Expression on Human
T Cells.
 
We hypothesized that infection of T lympho-
cytes by HSV1 could pose a severe risk for the antiviral im-
mune response because the infected cells could present viral
antigen to and thereby kill each other (fratricide). Previous
studies have demonstrated that HSV1 efficiently interferes
with antigen presentation in human fibroblasts due to its
ability to block transport of MHC class I molecules (13,
14). This effect, however, can vary in different cell types.
Therefore, we investigated the efficiency of HSV1’s block-
ing of the transport of MHC class I molecules in human T
cells compared with human fibroblasts. For this purpose,
the human fibroblast cell line MRC-5 and activated human
CD8
 
1
 
 lymphocytes were infected with a recombinant
HSV1 strain coding for K
 
b
 
, a murine MHC class I molecule
(F-US5MHC). Infection of both cell types was efficient, as
shown by FACS™ analysis of gD, a strongly expressed
HSV1 glycoprotein (Fig. 1, bottom panels). Expression of
endogenous MHC class I molecules and of virus-encoded
K
 
b
 
 was analyzed in parallel. Human fibroblasts infected with 
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F-US5MHC illustrated the effective viral block of MHC
class I expression (Fig. 1, left): virus-encoded K
 
b
 
 could not be
detected, and the level of endogenous MHC class I molecules
was reduced by 
 
z
 
50% 5 h after infection. By contrast, we
could detect the viral K
 
b
 
 on the cell surfaces of human CD8
 
1
 
lymphocytes (Fig. 1, right) and, in addition, we observed
no inhibitory effect on the expression of endogenous MHC
class I molecules 5 h after infection. These results demonstrate
that, in contrast to its effect on human fibroblasts, HSV1 does
not inhibit MHC class I expression by human T cells.
 
Fratricide of Human HSV1-reactive T Cell Lines after HSV1
Infection.
 
It has been demonstrated that freshly activated T
cells are resistant to apoptosis and, in addition, that HSV1
itself confers resistance to apoptosis in certain cell types (15,
32). To study the consequences of viral antigen presenta-
tion in antiviral T cell populations, we generated different
HSV1-reactive T cell lines from seropositive human donors
and from mice previously inoculated with HSV1 strain F.
As a control, polyclonally stimulated T cells and HCMV-
specific T cell lines were employed. HSV1-reactive and con-
trol cells expressed comparable levels of CD95 (data not
shown). Rapid apoptosis occurred after infection with the
HSV1 strain F (MOI of 10) in both murine and human
HSV1-reactive T lymphocytes. By contrast, significant cell
death was absent in polyclonally stimulated murine and hu-
man T lymphocytes and in HCMV-specific human T cell
lines (Fig. 2). Infection-mediated apoptosis of the specific
antiviral T cell lines suggests that HSV1 infection renders
antiviral T cells susceptible to apoptosis and that recogni-
tion of viral antigen may be necessary to initiate the cascade
of events that lead to fratricide. Like T cell clones or T cell
hybridomas, however, T cell lines are especially susceptible
to induction of apoptosis and might not reflect the situation
in vivo, where freshly activated antiviral CTLs eliminate
the invading pathogen. Therefore, we developed a system
to investigate the above effects in mice.
 
A Transgenic Mouse Model of HSV1 Infection as a Tool to
Further Dissect the Mechanisms Involved in HSV1 Fratricide.
 
Molecular analysis of freshly activated antiviral CTLs is ham-
pered by the fact that T cells reactive to a particular virus oc-
cur only at a low frequency in the peripheral T lymphocyte
pool. To circumvent this problem, we employed a trans-
genic mouse model of HSV1 infection for further analysis of
HSV1-induced fratricide. In this model, TCR-transgenic
mice that express a T cell repertoire strongly skewed toward
K
 
b
 
 (Des.TCR mice) serve as the hosts and F-US5MHC
virions encoding K
 
b
 
 as a viral neoantigen are used as infec-
tious particles. First, we tested whether the transgenic TCR
can recognize viral K
 
b
 
 on murine cells as a target structure.
For this purpose, we infected the murine mastocytoma cell
line P815 (MHC haplotype H-2
 
d
 
) with F-US5MHC. As
demonstrated by analysis of gD, the P815 cells were effi-
ciently infected with F-US5MHC (Fig. 3 A, right). How-
ever, these cells showed only weak expression of K
 
b
 
 in com-
parison to stable transfectants constitutively expressing K
 
b
 
under the control of a strong promotor (P815-K
 
b
 
 cells) (Fig.
3 A, left). Nonetheless, the K
 
b
 
-reactive CTLs from Des.TCR
Figure 1. Levels of virus-encoded Kb and endogenous MHC class I mol-
ecules on human fibroblasts and CD81 T cells infected with HSV1. The
human fibroblast cell line MRC-5 (left) and human Con A–activated
PBMCs (right) were infected with Kb-encoding HSV1 strain F-US5MHC
at an MOI of 10 (unfilled curve), HSV-1 strain F at an MOI of 10 (black
curve), or mock infected (gray curve). After incubation for 5 h, cells were
stained for viral Kb, endogenous MHC class I molecules, and viral gD us-
ing a primary mAb followed by an isotype-specific FITC-labeled second-
ary reagent. PBMCs were subsequently stained with a PE-conjugated
anti-CD8 mAb, and data were electronically gated for CD81 cells. The
x-axis shows fluorescence intensity (log scale, four decades), and the
y-axis depicts the relative cell number. The results shown are representa-
tive of three independent experiments.
Figure 2. Fratricide of HSV1-reactive human and murine T cell lines.
HSV1-reactive T cell lines from mice and human donors were isolated as
described in Materials and Methods. The expanded T cells were infected
with HSV1 strain F at an MOI of 10 and analyzed in a JAM assay 5 h after
infection to measure the degree of cell death. As controls, polyclonally acti-
vated human and murine T cells and HCMV-reactive T cell lines were
treated in the same way. One of three independent experiments is depicted. 
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mice could recognize and kill F-US5MHC–infected P815
cells (Fig. 3 B). The obtained lysis was relatively weak in
comparison to lysis of P815-K
 
b
 
 cells, reflecting the weak
K
 
b
 
 expression of F-US5MHC–infected P815 cells. In con-
trast, we observed no lytic activity against target cells infected
with a recombinant HSV1 strain encoding lacZ (F-US5b)
as a control. Thus, the transgenic TCR recognizes virus-
encoded Kb as a target structure on infected cells.
We then investigated whether fratricide also applied to
F-US5MHC–infected T lymphocytes from Des.TCR mice.
After F-US5MHC infection, we detected viral Kb on the
cell surfaces of activated murine T cells (Fig. 4 A). Consis-
tent with this observation, we detected rapid apoptosis in
the JAM assay in activated T cells from Des.TCR mice af-
ter infection with F-US5MHC but not after F-US5b in-
fection (Fig. 4 B). As a further negative control, we used
Con A–activated T lymphocytes from DBA/2 mice. In
these cells, expression of HSV1-encoded genes was as effi-
cient as in activated Des.TCR lymphocytes (data not
shown), but the cells did not show an enhanced rate of
DNA fragmentation after F-US5MHC infection (Fig. 4 B).
In addition, we analyzed whether expression of the Kb
antigen by means other than F-US5MHC infection results
in a significant increase in death of Des.TCR lymphocytes.
For this purpose, activated but uninfected Des.T cells were
incubated with P815-Kb transfectants that express much
higher levels of Kb than F-US5MHC–infected cells. After
7 h, only a slight increase in DNA fragmentation (i.e., 3%)
occurred in comparison to that in activated Des.TCR cells
that had been incubated with Kb-negative P815 cells (data
not shown). Thus, the observed fratricide was dependent
on HSV1 infection and occurred not only in long-term–
cultured T cell lines but also in freshly activated CTLs,
which comprise a high proportion of antigen-reactive T
cells. These results demonstrate that Des.TCR mice, in
combination with F-US5MHC, represent a suitable model
with which to analyze the underlying mechanisms of
HSV1-induced fratricide.
Figure 3. CTLs from Des.TCR mice recognize viral Kb as a target
structure. (A) FACS™ analysis of Kb expression on target cells. P815 cells
were infected with either F-US5MHC (unfilled curve) or F-US5b (black
curve) at an MOI of 10 or mock infected (gray curve). After incubation
for 5 h, the cells were stained for Kb (left) or gD (right). As a positive con-
trol, uninfected P815-Kb transfectants strongly expressing Kb (gray curve
marked P815-Kb) were stained for Kb. The x-axis shows fluorescence in-
tensity (log scale, three decades), and the y-axis depicts the relative cell
number. (B) In parallel, target cells were used in a 51Cr-release assay. The
x-axis shows the E/T ratio, whereas the y-axis depicts specific lysis (%).
Results are representative of three independent experiments.
Figure 4. F-US5MHC infection and fratricide of Des.TCR cells. (A) Lev-
els of viral Kb and glycoprotein gD on activated murine T cells infected with
F-US5MHC (unfilled curve). As a control, cells were infected with F-US5b
(black curve) or mock infected (gray curve). After incubation for 5 h, the
cells were stained for viral Kb and gD using a primary mAb followed by an
isotype-specific FITC-labeled secondary reagent. Splenocytes were subse-
quently stained with PE-conjugated anti-CD8 mAb, and data were elec-
tronically gated for CD81 cells. (B) Fratricide of Des.TCR cells after infec-
tion with F-US5MHC. For the JAM assay, cells were labeled with tritiated
thymidine and then infected either with F-US5MHC or F-US5b as a con-
trol and incubated for 7 h before harvesting and measuring [3H]thymidine.
The y-axis gives the degree of fragmentation of labeled target cell DNA in
response to cytotoxic attack, whereas the x-axis depicts the MOI. One rep-
resentative experiment of three is shown.1108 HSV1-induced Fratricide of Activated Antiviral T Cells
Mechanisms of Fratricide. There are two known main
antigen-dependent pathways by which CTLs can kill virus
infected-cells: killing by the perforin/granzyme system and
killing by molecules that belong to the TNF cytokine fam-
ily (33). Nearly all of the cytotoxicity mediated by CD81
CTLs is due to the perforin/granzyme system. Therefore, we
analyzed whether perforin was involved in HSV1-induced
fratricide. For this purpose, CTLs from either Des.TCR
mice or Des.TCR mice lacking perforin (Des.TCR 3
perforin2/2) were infected with F-US5MHC. Surprisingly,
we detected identical levels of apoptosis in the JAM assay,
indicating that HSV1-induced fratricide was perforin inde-
pendent (Fig. 5 A). To further dissect the molecular events
underlying HSV1-induced apoptosis, we investigated whether
apoptosis-inducing members of the TNF cytokine family,
namely TNF, CD95L, and TRAIL, play a role in HSV1-
induced fratricide by blocking the activity of the respective
ligands with receptor–Fc fusion proteins. In addition, we de-
termined whether antigen recognition is necessary to trigger
the apoptogenic signaling cascade. To this end, we used an
anti-Kb mAb to inhibit the interaction between the trans-
genic Kb-reactive TCR and the Kb molecule (Fig. 5 B).
We found that upon infection of activated Des.TCR CTLs
with F-US5MHC, inhibition of the CD95–CD95L interac-
tion substantially prevented apoptosis, blocking of TRAIL
had virtually no effect, and inhibition of TNF partially abro-
gated apoptosis. Interestingly, blocking of the TCR–Kb inter-
action also prevented apoptosis after F-US5MHC infection of
activated T lymphocytes from Des.TCR mice.
Given the importance of the CD95–CD95L interaction in
HSV1-induced fratricide, we next examined the expression
of CD95L and its receptor on infected CD81 lymphocytes
(Fig. 6). Interestingly, CD95L was upregulated on activated
Des.TCR CD81 T cells only after productive infection with
F-US5MHC but not after infection with F-US5b, implying
that triggering of the transgenic TCR by Kb resulted in
higher surface expression of CD95L on activated CTLs.
Supporting these data, levels of CD95L remained unchanged
on HSV1-infected nontransgenic murine T cells, which are
not antigen specific. Thus, HSV1 infection per se does not
induce higher expression of CD95L on activated T lym-
phocytes 5 h after HSV1 infection. In contrast to CD95L,
the expression of its receptor was not significantly altered,
regardless of whether the HSV1-infected T cells recog-
Figure 5. HSV1-induced fratricide is primarily mediated by CD95 sig-
naling and requires a further signal through TCR–MHC interaction. (A)
CTLs from Des.TCR mice or Des.TCR perforin2/2 transgenic mice
were infected with F-US5MHC and then used in a JAM assay to measure
DNA fragmentation. (B) JAM tests using chimeric human Fc–murine
CD95 to block CD95L, chimeric human Fc–murine TRAILR2 to block
TRAIL, and chimeric human Fc–TNFR2 to block TNF. In addition, Kb
was blocked with an mAb against Kb (clone AF6-88.5). One representa-
tive experiment of three is shown.
Figure 6. Expression of CD95L and its receptor on Con A–stimulated
CD81 T cells from Des.TCR and DBA/2 mice after HSV1 infection. Top
panels: activated T cells from DBA/2 mice (left) or Des.TCR mice (right)
were infected with either F-US5MHC (unfilled curve) or F-US5b (black
curve) at an MOI of 10, and cells were stained for CD95L after 5 h. Bot-
tom panels: activated T cells from DBA/2 mice (left) or Des.TCR mice
(right) were infected with HSV1 strain F (unfilled curve) at an MOI of 10
or mock infected (gray curve) and stained for CD95 after 5 h. All cells were
stained with a PE-conjugated anti-CD8 mAb, and data were electronically
gated for CD81 cells. The x-axis shows fluorescence intensity (log scale,
three decades), and the y-axis depicts the relative cell number. The results
shown are representative of three independent experiments.1109 Raftery et al.
nized antigen or not. Thus, an enhanced level of CD95L
expression is relevant for HSV1-induced fratricide, whereas
upregulation of CD95 expression is not required. Alto-
gether, these findings demonstrate that the CD95 system is
the main effector system of HSV1-induced fratricide and,
in addition, that the virus-induced increase of CD95L ex-
pression is dependent on TCR–antigen interaction.
Sensitization of HSV1-infected T Cells for CD95-mediated
Apoptosis Due to a Viral “Competence-to-Die” Signal. Virus-
induced upregulation of CD95L is necessary but not suffi-
cient for induction of fratricide, as freshly activated T cells
are normally resistant to CD95 signaling. Therefore, we de-
termined whether HSV1 renders activated T cells suscepti-
ble to CD95 triggering after infection. For this purpose, we
used the superantigen SEB to stimulate PBMCs. SEB acti-
vation is similar to normal activation with antigen because
it also requires APCs and a CD28 costimulation signal and
yields activated T cells that are resistant to apoptosis induc-
tion via CD95 (34). After SEB activation, PBMCs were in-
fected with HSV1 or, as a control, left uninfected and sub-
sequently challenged with apoptosis-inducing anti-CD95
mAb (Fig. 7). We found that HSV1-infected CD81 and
CD41 T cells are highly susceptible to CD95-mediated ap-
optosis, whereas the majority of uninfected T lymphocytes
and T lymphocytes treated with UV-inactivated virus par-
ticles (mock infection) remained resistant to CD95 ligation.
Similar data were obtained when PHA was used instead of
SEB to stimulate T lymphocytes (data not shown). These
results demonstrate that triggering of CD95 alone is not
sufficient for induction of fratricide. Only in the course of
productive HSV1 infection is an additional viral compe-
tence-to-die signal generated that renders short-term–acti-
vated T cells sensitive to CD95-mediated apoptosis.
Discussion
In this paper, we analyzed the functional implications of
HSV1 infection of activated T cells. We observed that, in
contrast to human fibroblasts, MHC class I expression on
HSV1-infected human T lymphocytes is not disrupted. This
supports the notion that the efficiency of HSV1’s interfer-
ence with transport of peptides into the lumen of the endo-
plasmic reticulum varies not only in different species (13,
35, 36) but also in different cell types of the same species
(13). As a consequence of unaltered presentation of viral
antigens by MHC class I molecules, antiviral CTL popula-
tions infected with HSV1 are rapidly eliminated. In theory,
this could either be due to suicide of individual CTLs or,
alternatively, fratricide (killing of each other). We prefer
the latter because antigen recognition by infected T cells
was required for induction of apoptosis, and it has been
shown that TCR molecules are unable to interact with
MHC–peptide complexes on the same cell (19).
To identify the molecules involved in virus-induced frat-
ricide, we used a transgenic mouse model of HSV1 infec-
tion. CTLs from mice expressing a Kb-reactive transgenic
TCR (Des.TCR mice) were infected with a recombinant
HSV1 strain coding for Kb (F-US5MHC). Blocking experi-
ments revealed that HSV1-induced fratricide is mainly trig-
gered by the CD95–CD95L system. Intriguingly, blocking
CD95 did not totally prevent cell death, as TNF also con-
tributed to fratricide, although to a lesser extent. In con-
trast, TRAIL, another member of the TNF family, was not
involved. Similarly, perforin did not play a role in HSV1-
induced fratricide, because T lymphocytes from Des.TCR 3
perforin2/2 mice were as susceptible to apoptosis as T cells
from Des.TCR mice. Blocking of the TCR–antigen inter-
action reduced fratricide to the same extent as blocking
CD95. As an explanation, we found that activated CTLs
from Des.TCR mice further upregulated CD95L molecules
on the cell surface within a few hours after infection with
Kb-encoding HSV1. Such a rapid upregulation may be due
to recruitment of preformed CD95L molecules rather than
to de novo synthesis (37, 38). This result, together with the
fact that rapid cell death was not induced in human T cell
lines reactive with CMV, suggests that signaling through
Figure 7. HSV1 infection renders T cells susceptible to
CD95-mediated apoptosis. Human PBMCs were acti-
vated with SEB for 24 h before being either infected with
HSV1 strain F or left uninfected. As a further control,
cells were infected with UV-inactivated HSV1 particles
(mock infection). Subsequently, cells were incubated
with apoptosis-inducing anti-CD95 mAb. After 18 h,
cells were stained with Cy-Chrome–conjugated anti-
CD8 or anti-CD4 mAb, fixed, and TUNEL stained as
described in Materials and Methods. The results shown
are representative of three independent experiments.1110 HSV1-induced Fratricide of Activated Antiviral T Cells
the TCR complex after recognition of viral antigen is a
prerequisite of HSV1-induced fratricide and may be the
basis of viral immune evasion. In this aspect, it resembles
FasL- and TNF-mediated mechanisms that induce periph-
eral tolerance and maintain physiological lymphocyte ho-
meostasis (39).
It has been shown that uninfected T cells acquire a tran-
sient state of resistance to CD95-mediated signaling after
activation lasting several days (32). Therefore, we have
compared the susceptibility of HSV1-infected versus unin-
fected T lymphocytes to CD95-mediated apoptosis after
SEB stimulation. As previously reported, SEB stimulates
both CD41 and CD81 T cells (40) and confers resistance to
CD95-induced apoptosis in freshly activated T cells (34).
We found that subsequent HSV1 infection renders SEB-
activated CD41 and CD81 T cells highly susceptible to in-
duction of apoptosis through engagement of CD95 by
mAbs. In contrast, abortive infection with UV-inactivated
HSV1 did not confer susceptibility to CD95 signaling. This
result implies that viral proteins expressed in the course of
productive infection facilitate activation-induced cell death
(AICD). Such a competence-to-die signal (41) has recently
been demonstrated by stimulating uninfected T lympho-
cytes with variant peptide ligands that do not induce T cell
effector functions (e.g., cytokine secretion). This does not
result in upregulation of death receptors on “competent” T
lymphocytes but renders them susceptible to death ligands
on neighboring cells. However, the molecular basis of this
phenomenon has yet to be defined, although tyrosine phos-
phorylation of intracellular proteins could play a role (42).
Taken together, these data suggest that apoptosis of acti-
vated T cells requires two distinct signals: one that leads to
upregulation of CD95/CD95L and another that removes
the block of CD95-signaling pathways at the time of CD95
triggering. AICD is triggered by repeated antigenic stimu-
lation (43–45). Accordingly, HSV1 proteins could lower the
AICD threshold, the critical number of triggered TCRs
during TCR–peptide–MHC interaction. It is unlikely that
the viral proteins target expression or function of antiapop-
totic proteins of the Bcl family like Bcl-xL or Bcl-2, because
it has been reported that AICD is not prevented by these
molecules (46). Alternatively, HSV1 proteins could restore
the formation of the death-inducing signaling complex
(DISC), which has been shown to lack FLICE (FADD-like
IL-1b–converting enzyme, now referred to as caspase-8;
reference 47) in freshly activated T cells that are resistant to
AICD (48). This could be accomplished by downregula-
tion of the antiapoptotic cellular FLIP (FLICE-inhibitory
protein), which competes for caspase-8 recruitment to the
DISC (49–54). Thus, the viral proteins involved in facili-
tating AICD and the molecular basis of this effect remain to
be elucidated.
Fratricide has also been implicated as an important factor in
the pathogenesis of AIDS (55). T cells from HIV-1–infected
individuals show upregulation of CD95/CD95L and en-
hanced susceptibility to CD95-mediated killing (56–59).
Moreover, HIV-1–derived proteins (Tat, gp120) can en-
hance CD95L expression (55, 60). Recently, it has been
demonstrated that Nef, another HIV-1 protein, forms a
signaling complex with the TCR. This results in T cell ac-
tivation and upregulation of CD95L expression, thereby
circumventing the need for antigen recognition (60). In
this way, HIV may cause global immunodeficiency, which
finally results in opportunistic infections and death of the
infected individuals.
We propose a different mechanism underlying fratricide
in active HSV1 infections (Fig. 8). In HSV1 lesions, which
usually remain focused to an area of epithelial cells, free vi-
rions can infect invading antiviral CTLs by binding to her-
pesvirus entry mediator (HVEM) molecule. Subsequently,
viral antigens are efficiently presented on infected antiviral
CTLs. Neighboring CTLs that recognize viral antigen up-
regulate CD95L. In addition, HSV1 lifts the block for
AICD. As a consequence, infected antiviral CTLs could be
better targets than infected epithelial cells, in which antigen
presentation via MHC class I molecules is prevented by viral
proteins. Such a cell type–specific regulation of viral defense
mechanisms could turn antiviral CTLs into decoy targets,
thereby enhancing local spread of the virus in epithelial cells.
The elimination of antiviral CTLs by antigen-dependent
fratricide could be a general immune evasion mechanism
employed by viruses that can infect and replicate in acti-
vated T cells, although they mainly propagate in nonlym-
phoid cells. In contrast, viruses that are dependent on T cells
for virion production (e.g., human herpesviruses 6 and 7)
may have to prevent T cell death to yield enough infec-
tious particles.
Figure 8. HSV1-induced fratricide of antiviral CTLs as a mechanism of vi-
ral immune evasion. Antiviral CTLs activated in the draining lymph nodes
enter the epithelial lesions, where they are infected by HSV1 virions (1). Due
to inefficient activity of the TAP (transporter associated with antigen process-
ing) blocker in T lymphocytes, viral antigens are presented via the MHC class
I molecules and recognized by neighboring CTLs (2). In addition, HSV1 lifts
the block for CD95-mediated death signals, resulting in fratricide (3).1111 Raftery et al.
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